Therefore, we used computational methods to address the ability of compounds to modulate three major targets in depression, namely SERT, 5-HT1A, and D2 receptors and compared their predicted effect with the effect of potent drugs used in clinics. The gene discussed is HTR1A; the disease is depressive symptom measurement.